Objective: To evaluate seizure outcome following epilepsy surgery for patients with temporal lobe epilepsy and evaluate is gender and race/ethnicity influence it. Methods: Data were obtained from the discharge database of the University of Alabama at Birmingham, Epilepsy Center, between 1985 and 2001 . The sample consisted of all patients with a primary diagnosis of medically intractable temporal lobe epilepsy (TLE) who underwent anterior temporal lobectomy. Seizure recurrence was tabulated at 7 days, 2 months, 6 months, 1, 2, 3, 4, 5, and 6 years following surgery. Logistic regression analysis was used to model the presence of seizure recurrence after anterior temporal lobectomy for all patients. Kaplan-Meier analysis was done to obtain estimates and 95% CIs of seizure freedom from baseline. Baseline variables -age at surgery, age at seizure onset, sex, side of resection, immediate postoperative seizures, and pathology results -were assessed as potential predictors of each outcome by comparing the survival curves within each variable with a log rank test. Results: Three hundred sixty-eight patients underwent surgical treatment for TLE, mean age of 30.2 years. Thirty-five patients were African American, 43% were men. Immediate postoperative seizures were seen in 23 patients, while seizure recurrence occurred in 27.3% patients within a year after surgery, and in 33.6% within 6 years. Logistic regression results showed no differences between African Americans and whites, between males and females. The occurrence of immediate postoperative seizures was a strong predictor of late seizure recurrence only at 1 year after surgery.
Introduction
Anterior temporal lobectomy (ATL), a recognized treatment for medically refractory temporal lobe epilepsy (TLE) for several decades, has been recently shown to be very effective when compared to medical treatment in a randomized controlled trial. 1 This study however, presented outcomes of seizure freedom for only 1 year after the surgical procedure.
Various studies have presented data regarding long-term outcomes. These data come from various centers, bringing variability associated with different surgical techniques and clinical evaluations. On the other hand, most of the studies from single centers recruited only small samples of patients. 2 This study is a relatively large retrospective analysis of seizure outcome and its predictors (particularly gender and race/ethnicity) in patients who underwent ATL at a single center from 1985 through 2001. Focus was placed on gender and race/ethnicity as we found in a recent study that these variables appeared to be associated with seizure outcome.
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Methods
Outcomes of 368 consecutive patients who underwent ATL for therapy resistant TLE at the Epilepsy Centre of the University of Alabama at Birmingham, between 1985 and 2001 were analyzed.
Sample
All patients discharged with a primary diagnosis of medically intractable TLE were identified. The diagnosis was based on the confirmation of an ictal onset in either temporal region by seizure monitoring with video-electroencephalography (EEG) that included the following findings: Interictal temporal lobe epileptiform and nonepileptiform disturbance of cerebral activity, semiology consistent with temporal lobe origin, and ictal EEG with either initial or delayed focal patterns. Intracranial EEG confirmation was required in a subset of patients.
Magnetic resonance imaging
All patients underwent imaging on a 1.5-T MRI system using standardized protocols. We acquired sagittal and coronal T1-weighted, coronal T2-weighted spin echo, fluid-attenuated inversion recovery, and inversion recovery sequences. We diagnosed MTS on the basis of evidence of hippocampal atrophy and abnormal signal alterations according to validated diagnostic criteria. 5, 6 Surgery and outcome
All patients who decided to undergo surgery for TLE due to hippocampal sclerosis, malformations of cortical development, and tumors in the mesial temporal region, underwent a resection of 4.5-5.5 cm of neocortex (anterior temporal lobe) and a targeted resection of the amygdala and hippocampus (including the anterior two thirds or the entire hippocampus). The technique has been reported in detail previously. 7 Patients underwent regular assessment for postoperative seizure control by the treating neurologist in periodic follow-up visits in their respective epilepsy clinic. All patients had at least 1 year of follow-up. Outcome at the most recent follow-up was classified as seizure free or not seizure free. Seizure free was defined as Engel Class I. We also included patients who still had auras (Engel I), including in the immediate postsurgical period, defined as 7 days after surgery.
Pathological analysis
Representative tissue samples of the hippocampus were routinely obtained for analysis. Specimens were fixed in formalin and embedded in paraffin. Histologic sections of the hippocampus and temporal lobe were stained with hematoxylin-eosin and glial fibrillary acidic protein. We diagnosed MTS according to the presence of neuronal loss in the cornu ammonis (CA) 1 and CA3-4 regions of the hippocampus by qualitative criteria. If the pathological findings were not diagnostic for MTS (inadequate sample), the patient was included on the basis of MRI identification of MTS. Other diagnosis were based on the histopathologic evaluation of the lesions (e.g., tumors, malformations of cortical development).
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Study variables
Independent variables consisted of race/ethnicity, age at surgery, age at habitual seizure onset, sex, lateralization of temporal epileptogenic focus, immediate postoperative seizures, and pathological results. Two specific ethnic groups constituted the race/ethnicity variable: African American and white. Ethnicity was registered by the treating physician, always corroborating with the patient's last name.
The following three specific age categories were used: younger than 25, 25-34, and 35 years or older.
Analysis methods
Multivariate logistic regression was used to investigate the relationship between seizure recurrence and race/ethnicity, with potential confounders controlled. Two sets of logistic regression models were estimated to generate odds ratios (ORs) for seizure recurrence after surgery for African American compared to white patients, and for men compared to women, at 1 and 6 years following surgery. The first model incorporated only ethnicity and gender as the independent variables and generated unadjusted ORs for having seizure recurrence. The second set included all independent variables described in the preceding subsection. Statistics were computed with SAS version 9.0 software (SAS Institute Inc., Cary, NC). Kaplan-Meier survival analysis was performed to obtain estimates and 95% CIs of seizure freedom from baseline. Baseline variables -age at surgery, age at seizure onset, sex, side of resection, immediate postoperative seizures, and pathology results -were assessed as potential predictors of each outcome by comparing the survival curves within each variable with a log rank test. For each outcome, landmark analyses were performed by obtaining yearly survival estimates at 1 through 6 years after surgery, and stratifying by whether patients were seizure free (or not) through the landmark. The Kaplan-Meier analysis provides survival estimates that are robust to variations in follow-up duration because patients are included in the estimates of survival to the time they Unadjusted and adjusted (including the following variables: gender, age at surgery, age at epilepsy onset, pathology, side of surgery, seizure frequency, and immediate postoperative seizures).
experience the outcome event (first seizure) or are lost to follow-up or death if no event occurred. We assumed that the length of follow-up available for a patient was not related to seizure status or severity but, rather, was a random process. Hazard ratios and p values were obtained from Cox proportional hazards analyses. Like odds ratios, a value of one represents no difference; p < 0.05 was considered to be significant.
Results
Three hundred sixty-eight patients underwent surgical treatment for TLE. Their mean (S.D.) age was 30.2 (0.6) years. Thirty-five patients were African American. Men represented 43% of the sample; 56% had left-sided TLE; 27% had <4 seizures per month, 34% had 4-9, and 39% had >9. MTS was found to be present in 66% of patients, 6% had normal pathological evaluation, and 28% had other pathology (gliosis, malformations of cortical development, tumors, between others). Immediate postoperative seizures were seen in 23 patients, while seizure recurrence occurred in 27.3% patients within a year after surgery, and in 33.6% within 6 years.
Logistic regression results are shown in Table 1 . Model 1 includes unadjusted ORs while in the multivariate logistic regression analysis we controlled for all independent variables (model 2). No significant differences were found between African Americans and whites in age at onset, age at surgery, sex, pathology, side of surgery, seizure frequency, and immediate postoperative seizures ( p values >0.10).
No differences were found between males and females, African Americans and whites, groups of age at presentation (<25, 25-34, and >34 years), side of surgery (left vs. right), seizure frequency (<4, 4-9, and >9 seizures per month), underlying pathology (MTS, gliosis, normal tissue, and other) and age of onset (<5, 5-14, and >14 years old); with the exception of the occurrence of immediate postoperative seizures, which was a strong predictor of late seizure recurrence only at 1 year after surgery. The Cox proportional hazard analysis did not reveal any differences (Table 2) .
Six-year survival in terms of seizure recurrence was 33.4% for women and 29.9% for men (log rank p = 0.185). For race/ethnicity the log rank was p = 0.615 (see Figs. 1 and 2 ).
Discussion
Assessment of long-term outcomes is essential in epilepsy because it is a chronic condition, and in brain surgery for epilepsy specifically because the effects are irreversible. While earlier studies traditionally focused on relatively short outcomes, epilepsy surgery centers are now reporting long-term outcomes in cohorts of patients with epilepsy following a variety of surgical interventions. Regardless of follow up duration, the strength of inference that can be derived from these studies is less robust than that from randomized controlled trials. Nonetheless, data from cohort studies still inform clinical practice in many areas, including epilepsy. The question of long-term outcomes may not be amenable to randomized trials due to feasibility and ethical issues. 8 Epilepsy outcomes following temporal lobe surgery have been studied extensively in recent years. A review of studies with 1-5 years of follow-up, 9 reported freedom of disabling seizures in 63.2% of patients (95% CI = 60, 66) and identified a trend for better outcomes in more recent reports. Long-term follow-up studies of temporal lobe epilepsy surgery reveal a slightly lower seizure-free rate (median 58% in studies using author defined outcomes, and 65% in those using Engel's class I classification), and a narrower range of seizure-free rates (59-89%). However, the results are more similar than different. In fact, one of our most salient findings is that, overall, long-term surgical results were consistently similar to those of short-term studies, including those from a randomized trial. 1 This supports the durability of the benefits of surgery in general.
When analyzing the different independent variables, we were surprised that pathological diagnosis did not have any influence in seizure outcome. In a previous study, patients with MTS appeared to be at a slightly increased risk of recurrent seizures compared with those with foreign tissue lesions and normal pathology. 10 In that series, all recurrences in patients with MTS occurred after 30 months. Explanations for these findings include the presence of dual pathology, bilateral TLE, and incomplete resection of the epileptogenic zone, which was the case in 10 of 11 patients who had recurrent seizures 10 years after ATL. 11 In our study, no differences were found in between the different pathologies, and the reason is unknown.
In terms of race/ethnicity, using prospectively collected data, we found that seizure outcomes at 1 and 6 years after temporal lobectomy for mesial TLE were similar among whites and African American patients. Although, we previously found lower rates of epilepsy surgery in African American patients compared with white patients, and although a clear explanation was not found, this was not related to access to health care in the African American group. 12 As we previously reported, a trend for higher rates of seizure recurrence was demonstrated in African American compared with white patients. However, that study was limited by the small sample size and the retrospective design. 3 Subsequently, we confirmed that no racial/ethnic differences were found in a study that included two major epilepsy centers in the US. 4 The sample of patients in the current study is larger giving better accuracy to the results.
Potential limitations of this study include limited geographic sampling, a small sample size for African Americans, lack of patients of other racial/ethnic backgrounds, and the methodology for ethnic classification. First, although the patient population consisted of white and African American patients, the information came from one epilepsy center, and it is not representative of the general population because other racial/ethnic groups such as Hispanics and Asians were not included. The main reason is that the bi-racial population in the state of Alabama has not changed in the rural areas, despite the fact that the urban centers are becoming more diverse (a phenomenon seen only in of recent years). Second, the small sample size of African Americans has to do with the disparities we found in our previous study. 12 African Americans were found to have the same access to presurgical evaluation, but they did not pursue the surgical treatment as often; the reasons for this remain unknown. Finally, the potential misclassification of race/ethnicity remains an issue, particularly with Hispanic patients; although the name origin can help with this, reports of race/ ethnicity can be subjective and are infrequently validated. 13 This important consideration is not unique to our analysis.
14 Nonetheless, it is unlikely that systematic underreporting or overreporting of a particular group is correlated with the propensity to perform invasive treatments like surgery.
We need to examine race/ethnicity subgroup data when possible (especially when previous work suggests significant differences by race or ethnicity), as recommended by the National Institutes of Health. Current evidence-based knowledge does not allow us to know the potential relationship between race/ethnicity and trial outcomes, and this lack of understanding constitutes a barrier to using results of clinical research to address racial/ethnic disparities in health. 15 The finding that immediate postoperative seizures predict seizure recurrence at 1 year but not at 6 years warrants a brief discussion. Explanations for this finding would include the non-homogeneous pattern of discontinuation of antiepileptic medications, or that certain number of patients is going to relapse in any case, and immediate postoperative seizures are simply a marker for the relapse happening sooner rather than later. By the time we get to 6 years, the most of the patients who were going to relapse have relapsed, and we are left with the true successes. Ultimately the finding could be related to a sampling issue.
Finally, the Kaplan-Meier analysis did not reveal any influence of gender and race/ethni-city in long-term seizure outcome, corroborating what it was found with the logistic regression analysis.
In conclusion, sex and race/ethnicity do not appear to be predictors of long-term outcome following surgery for temporal lobe epilepsy.
